We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » India Proposes Waiving Some Local Clinical Trial Requirements
India Proposes Waiving Some Local Clinical Trial Requirements
An Indian clinical trial advisory body has recommended exempting some drugs, including those to treat cancer and hepatitis C, from a requirement that manufacturers conduct local Phase III trials as a condition of marketing approval.